AP NEWS

Botox (Allergan) 2017-2018 U.S. Promotional Audit Report - ResearchAndMarkets.com

September 24, 2018

DUBLIN--(BUSINESS WIRE)--Sep 24, 2018--The “Botox 2017 U.S. Promotional Audit Report” report has been added to ResearchAndMarkets.com’s offering.

The 5 Key Questions Addressed

How many physicians were reached by Botox through reportable promotional activity in 2017 and how does this compare to its peer set in the Blepharospasm, Facial Wrinkles, Glabellar Lines, Hyperhidrosis, Migraine, Muscle Spasticity, Overactive Bladder, Strabismus, and Torticollis markets? What promotional mix was leveraged (e.g., sales rep detailing, physician education, and paid speaking) and what was the median spend for each type of activity? How does Allergan’s depth of coverage vary within key specialties (e.g., Neurology, Urology, Physical Medicine and Rehabilitation, Anesthesiology, Obstetrics/Gynecology, Family Medicine, and Pain Medicine) and how does this compare to its peers and the overall set of rep-accessible physicians? How often are physicians receiving paid meals for Botox throughout the year (e.g., monthly, quarterly, annually)? Who were the most frequent meal recipients and top paid speakers for Botox in 2017?

Data Sources & Methodology

The author leverages company-reported financial transaction data disclosed through CMS Open Payments. This data set captures all transfers of value (e.g., speaking fees, consulting fees, travel, education, and meals) made on behalf of a drug or device manufacturer to a physician. More than four years of longitudinal data is available - covering payments to more than 975,000 U.S. healthcare professionals. Over 16,300 paid interactions across 7,100 physicians made on behalf of Botox were carefully examined to support the analysis.

For more information about this report visit https://www.researchandmarkets.com/research/lz297z/botox_allergan?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180924005444/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Central Nervous System Drugs

KEYWORD: UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/24/2018 07:13 AM/DISC: 09/24/2018 07:13 AM

http://www.businesswire.com/news/home/20180924005444/en

AP RADIO
Update hourly